• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

m5C修饰的长链非编码RNA SNHG15通过miR-545-3p/PD-L1轴促进卵巢癌进展。

m5C-Modified lncRNA SNHG15 Promotes Ovarian Cancer Progression Via the miR-545-3p/PD-L1 Axis.

作者信息

Chen Li, Ma Ruifeng, Wu Lei, Wang Dandan, Li Jingchao, Guo Li

机构信息

The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, No.41 Linyin Road, Kundulun District, Baotou City, 014010, Inner Mongolia, China.

出版信息

Reprod Sci. 2025 Jun 24. doi: 10.1007/s43032-025-01919-2.

DOI:10.1007/s43032-025-01919-2
PMID:40555907
Abstract

Ovarian cancer (OC) poses a health burden of women. Long non-coding RNA SNHG15 has been reported to promote OC progression; however, its effect on immune evasion remains unknown. Here, we investigated the effect of SNHG15 on OC cell immune evasion and the underlying mechanism. Cell phenotypes were assessed using cell counting kit-8, colony formation, lactate dehydrogenase cytotoxicity, and enzyme-linked immunosorbent assays. The mechanism was evaluated by dual-luciferase reporter assay, RNA pull-down, RNA immunoprecipitation (RIP), methylated RIP, and RNA stability assay. The role in vivo was analyzed using tumor-bearing mice. The results showed that SNHG15 and PD-L1 levels were increased, while miR-545-3p expression was reduced in OC. SNHG15 was a sponge of miR-545-3p, and PD-L1 was a downstream target of SNHG15. Knockdown of SNHG15 suppressed OC cell proliferation, and enhanced cytotoxicity and pro-inflammatory response of CD8 T cells, whereas miR-545-3p downregulation reversed these cellular behaviors. Moreover, PD-L1 reversed the cell phenotypes induced by miR-545-3p. Additionally, SNHG15 was modified by m5C, which was mediated by NSUN2. Furthermore, SNHG15 knockdown impeded tumor growth in mice. In conclusion, m5C-methylated lncRNA SNHG15 promotes OC progression by accelerating cell proliferation and immune evasion via the miR-545-3p/PD-L1 axis, demonstrating a tumor-promoting function of SNHG15 in OC.

摘要

卵巢癌(OC)给女性带来健康负担。据报道,长链非编码RNA SNHG15可促进OC进展;然而,其对免疫逃逸的影响尚不清楚。在此,我们研究了SNHG15对OC细胞免疫逃逸的影响及其潜在机制。使用细胞计数试剂盒-8、集落形成、乳酸脱氢酶细胞毒性和酶联免疫吸附测定来评估细胞表型。通过双荧光素酶报告基因测定、RNA下拉、RNA免疫沉淀(RIP)、甲基化RIP和RNA稳定性测定来评估机制。使用荷瘤小鼠分析其在体内的作用。结果显示,OC中SNHG15和PD-L1水平升高,而miR-545-3p表达降低。SNHG15是miR-545-3p的海绵,PD-L1是SNHG15的下游靶点。敲低SNHG15可抑制OC细胞增殖,并增强CD8 T细胞的细胞毒性和促炎反应,而miR-545-3p下调可逆转这些细胞行为。此外,PD-L1可逆转miR-545-3p诱导的细胞表型。另外,SNHG15由NSUN2介导进行m5C修饰。此外,敲低SNHG15可抑制小鼠肿瘤生长。总之,m5C甲基化的lncRNA SNHG15通过miR-545-3p/PD-L1轴加速细胞增殖和免疫逃逸,促进OC进展,证明了SNHG15在OC中的促肿瘤功能。

相似文献

1
m5C-Modified lncRNA SNHG15 Promotes Ovarian Cancer Progression Via the miR-545-3p/PD-L1 Axis.m5C修饰的长链非编码RNA SNHG15通过miR-545-3p/PD-L1轴促进卵巢癌进展。
Reprod Sci. 2025 Jun 24. doi: 10.1007/s43032-025-01919-2.
2
[LncRNA SNHG15 promotes proliferation, migration and invasion of lung adenocarcinoma cells by regulating COX6B1 through sponge adsorption of miR-30b-3p].[长链非编码RNA SNHG15通过miR-30b-3p的海绵吸附作用调控COX6B1,促进肺腺癌细胞的增殖、迁移和侵袭]
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Jul 20;45(7):1498-1505. doi: 10.12122/j.issn.1673-4254.2025.07.16.
3
LncRNA SNHG15 targets miR-200a-3p affects the proliferation, apoptosis, migration, and invasion of cervical cancer cells.长链非编码RNA SNHG15靶向miR-200a-3p影响宫颈癌细胞的增殖、凋亡、迁移和侵袭。
BMC Cancer. 2025 Aug 7;25(1):1279. doi: 10.1186/s12885-025-14600-3.
4
LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis.长链非编码 RNA XIST 通过靶向 miR-506-3p/FOXP1 轴激活自噬促进卵巢癌细胞对卡铂的耐药性。
J Gynecol Oncol. 2022 Nov;33(6):e81. doi: 10.3802/jgo.2022.33.e81.
5
LRRC75A-AS1 facilitates breast cancer cell proliferation and invasion via functioning as a CeRNA to modulate miR489-3p/ARD1.LRRC75A-AS1通过作为竞争性内源RNA(CeRNA)调节miR489-3p/ARD1促进乳腺癌细胞增殖和侵袭。
Sci Rep. 2025 Aug 26;15(1):31501. doi: 10.1038/s41598-025-17372-9.
6
Long non-coding RNAFOXD1-AS1 modulated CTCs epithelial-mesenchymal transition and immune escape in hepatocellular carcinoma in vitro by sponging miR-615-3p.长链非编码 RNAFOXD1-AS1 通过海绵吸附 miR-615-3p 调控肝癌细胞循环肿瘤细胞上皮间质转化和免疫逃逸的体外研究
Cancer Rep (Hoboken). 2024 Mar;7(3):e2050. doi: 10.1002/cnr2.2050.
7
CircAGFG1 Promotes Ovarian Cancer Progression Through the miR-409-3 p/ZEB1 Axis.环状 RNA AFGG1 通过 miR-409-3p/ZEB1 轴促进卵巢癌进展。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241252423. doi: 10.1177/15330338241252423.
8
Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis.上调 LINC01088 通过调控 microRNAs/G3BP1/PD-L1 轴促进结直肠癌的恶性表型和免疫逃逸。
J Cancer Res Clin Oncol. 2022 Aug;148(8):1965-1982. doi: 10.1007/s00432-022-03981-8. Epub 2022 Mar 31.
9
Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.长链非编码 RNA PVT1 通过调节卵巢癌细胞中的 miR-133a 促进细胞增殖和侵袭。
Biomed Pharmacother. 2018 Oct;106:61-67. doi: 10.1016/j.biopha.2018.06.112. Epub 2018 Jun 26.
10
Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC).环状 RNA circ-CPA4/let-7 miRNA/PD-L1 轴调控非小细胞肺癌(NSCLC)中的细胞生长、干性、耐药性和免疫逃逸。
J Exp Clin Cancer Res. 2020 Aug 3;39(1):149. doi: 10.1186/s13046-020-01648-1.

本文引用的文献

1
Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies.基于细胞的免疫疗法中的免疫逃逸:揭示挑战与新策略。
J Biomed Sci. 2024 Jan 12;31(1):5. doi: 10.1186/s12929-024-00998-8.
2
Revolutionizing cancer immunotherapy in solid tumor: CAR engineering and single-cell sequencing insights.颠覆实体瘤的癌症免疫治疗:CAR 工程和单细胞测序的见解。
Front Immunol. 2023 Nov 23;14:1310285. doi: 10.3389/fimmu.2023.1310285. eCollection 2023.
3
m5C-methylated lncRNA NR_033928 promotes gastric cancer proliferation by stabilizing GLS mRNA to promote glutamine metabolism reprogramming.
m5C 甲基化长非编码 RNA NR_033928 通过稳定 GLS mRNA 促进谷氨酰胺代谢重编程来促进胃癌增殖。
Cell Death Dis. 2023 Aug 15;14(8):520. doi: 10.1038/s41419-023-06049-8.
4
PD-1/PD-L1 immune checkpoint blockade in ovarian cancer: Dilemmas and opportunities.PD-1/PD-L1 免疫检查点阻断在卵巢癌中的应用:困境与机遇。
Drug Discov Today. 2023 Aug;28(8):103666. doi: 10.1016/j.drudis.2023.103666. Epub 2023 Jun 9.
5
The potential regulatory role of RNA methylation in ovarian cancer.RNA 甲基化在卵巢癌中的潜在调控作用。
RNA Biol. 2023 Jan;20(1):207-218. doi: 10.1080/15476286.2023.2213915.
6
Identification and validation of m5c-related lncRNA risk model for ovarian cancer.鉴定和验证 m5c 相关 lncRNA 风险模型在卵巢癌中的作用。
J Ovarian Res. 2023 May 15;16(1):96. doi: 10.1186/s13048-023-01182-6.
7
Long noncoding RNA SNHG15: A promising target in human cancers.长链非编码RNA SNHG15:人类癌症中一个有前景的靶点。
Front Oncol. 2023 Mar 28;13:1108564. doi: 10.3389/fonc.2023.1108564. eCollection 2023.
8
The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer.长链非编码RNA表观遗传学:m6A和m5C长链非编码RNA修饰在癌症中的意义
Front Oncol. 2023 Mar 9;13:1063636. doi: 10.3389/fonc.2023.1063636. eCollection 2023.
9
Burden of ovarian cancer in China from 1990 to 2030: A systematic analysis and comparison with the global level.中国卵巢癌负担:1990-2030 年的系统分析及与全球水平的比较
Front Public Health. 2023 Feb 13;11:1136596. doi: 10.3389/fpubh.2023.1136596. eCollection 2023.
10
RNA epigenetic modifications in ovarian cancer: The changes, chances, and challenges.卵巢癌中的RNA表观遗传修饰:变化、机遇与挑战。
Wiley Interdiscip Rev RNA. 2023 Sep-Oct;14(5):e1784. doi: 10.1002/wrna.1784. Epub 2023 Feb 21.